| Ytd | 29.71% | |
| 1y | -62.79% |
| Open | 1.15 | Prev Close | 1.15 | Low | 1.13 | High | 1.20 | Mkt Cap | 17.95M |
| Vol | 7.79K | Avg Vol | 321.35K | EPS | -0.60 | P/E | -1.92 | Forward P/E | N/A |
| Beta | 0.55 | Short Ratio | 0.87 | Inst. Own | 1.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.48 | 200-d Avg | 1.59 | 1yr Est | 0.00 |
AIFF News
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Depar
Firefly Neuroscience, Inc. (NASDAQ: AIFF - Get Free Report) was the recipient of a large decline in
- Firefly's total brain scan volumes have increased sequentially by higher percentages in each of th
Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Tre
Faraday Future Intelligent Electric shares up 54.8% in pre-market trading after SEC investigation en
Over 22 million Americans are diagnosed with ADHD — yet an objective biological marker for distingui
Firefly Neuroscience Inc. (NASDAQ: AIFF) shares are up on Friday as the company continues to make st
Firefly Neuroscience Inc. (NASDAQ: AIFF) shares are up on Wednesday as the company continues to deve
- Company reports 20-fold expansion of commercial footprint, 33-fold increase in EEG/ERP brain scan
Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) and SmartRent (NYSE: SMRT - Get Free Report) a
Aurora Innovation (NASDAQ: AUR - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free
Firefly Neuroscience, Inc. (NASDAQ: AIFF - Get Free Report) shares traded down 1.8% during mid-day t
Firefly Neuroscience, Inc. (NASDAQ: AIFF - Get Free Report)'s share price traded down 3.7% during tr
Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) and Wearable Devices (NASDAQ: WLDS - Get Free
– Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom
Firefly Neuroscience, Inc. (NASDAQ: AIFF - Get Free Report) saw a significant decline in short inter
NEW YORK , Oct. 9, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating F
KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”) (
– Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substant
– Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13
– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) --